Photographed on October 4, 2007 this image depicts Dr. John M. Dye, Jr., U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Viral Immunology branch chief, as he was working in the laboratory at the USAMRIID headquarters in Frederick, Maryland. Dr. Dye is leading a team that is conducting a study with nonhuman primates involving the experimental drug ZMapp, an experimental treatment for Ebola patients.
USAMRIID scientists here have worked for years on earlier versions of the Mapp Biopharmaceuticals cocktail of three different monoclonal antibodies. The drug is in Phase 1 clinical trials, but has not yet completed testing in people, for safety or effectiveness.
“From on-site laboratory support in Liberia, to training of key personnel, to accelerated research efforts on diagnostic, vaccine and treatment approaches, the USAMRIID is playing a significant role in assisting the Ebola Virus Disease outbreak response in West Africa.” See more about USAMRIID support for the Ebola Virus Disease outbreak by way of the link below.